三诺生物：目前公司暂未开展脑机接口领域相关业务

Core Insights - The company is focusing its exploration of artificial intelligence primarily on AI and chronic disease management, and has not yet engaged in brain-computer interface (BCI) related businesses [1] - The company emphasizes that it is not a core supplier of medical-grade electroencephalogram (EEG) signal acquisition devices [1] Group 1 - The company has developed an "AI + Brain-Computer" diabetes management platform in collaboration with Tencent Medical, which has over 2 million users [3] - The company has accumulated a significant amount of relevant data and data processing experience through partnerships with internet enterprises [3] - The company is collaborating with Qiang Brain Technology on a closed-loop brain-computer interface system in optogenetics, actively expanding its business in the brain-computer interface field [3] Group 2 - The company is a core supplier of medical-grade EEG signal acquisition devices, with its self-developed 128-channel EEG monitoring system having received CE certification [3] - This EEG monitoring system has been utilized in several top-tier hospitals for neuroscience research [3]